SCHEMBL11920184

SCHEMBL11920184

Cc1ccc(C(=O)c2ccc(C(C3=NC(C)C=C3)c3ccccc3)[nH]2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.36
SRD5A2 P31213 2/20 0.35
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 4/20 0.32
TP53 P04637 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
ALDH1A1 P00352 7/20 0.32
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
MAPT P10636 2/20 0.32
HTT P42858 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
RAB9A P51151 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14282584 0.86 AKR1C3 (0.44) AKR1C3SRD5A2TDP1LMNATP53
SCHEMBL8986306 0.81 AKR1C3 (0.40) AKR1C3SRD5A2TDP1LMNATP53
SCHEMBL13328292 0.79 ALDH1A1 (0.47) AKR1C3SRD5A2TDP1LMNACES2
SCHEMBL13638717 0.79 AKR1C3 (0.38) AKR1C3SRD5A2TDP1LMNATP53
SCHEMBL8986301 0.79 AKR1C3 (0.38) AKR1C3SRD5A2TDP1LMNATP53
SCHEMBL11922326 0.79 AKR1C3 (0.38) AKR1C3SRD5A2TDP1LMNATP53
SCHEMBL8986300 0.78 AKR1C3 (0.38) AKR1C3SRD5A2TDP1LMNATP53
SCHEMBL8986302 0.75 MEN1 (0.36) AKR1C3SRD5A2LMNATP53CES2
SCHEMBL8986303 0.74 LMNA (0.37) AKR1C3SRD5A2TDP1LMNATP53
SCHEMBL16270676 0.70 TDP1 (0.32) TDP1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120209009-A1 SYNTHETIC ROUTE TO ABCD-PORPHYRINS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120209009-A1 SYNTHETIC ROUTE TO ABCD-PORPHYRINS ABCB7, ALAD, SLC39A14 AKR1C3 1386/4885SRD5A2 1077/4885TDP1 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.